The global therapeutic vaccines market was valued at USD 28.40 Billion in 2024 driven by the advancements in vaccine technologies across the globe. It is expected to grow at a CAGR of 10.50% during the forecast period of 2025-2034 and attain a market value of USD 77.08 Billion by 2034.
Base Year
Historical Year
Forecast Year
The market is expected to witness significant expansion with the adoption of new technologies in vaccine development.
In June 2023, Nykode Therapeutics expanded its clinical partnership with Roche to advance VB10.16, a therapeutic cancer vaccine targeting advanced cervical cancer. Such partnerships and groundbreaking therapies are major trends that are contributing to market growth.
North America is expected to lead the market due to strategic alliances and support from both governmental and private organizations. Substantial investments in cancer and infectious vaccine research, along with advancements in personalized medicine, solidify the region’s leadership.
Therapeutic vaccines are designed to combat existing diseases by stimulating an immune response that targets and eliminates specific pathogens or cancer cells. The market is being driven by the rising incidences of chronic diseases, cancer, and infection, alongside recent technological advancements in vaccine developments. Key trends include increased investments in infectious disease vaccines and personalized medicine which will likely propel the market value in the coming years.
Rising Prevalence of Chronic Disease Drives Market Growth
The National Health Council reported that approximately 50 million Americans are affected by autoimmune diseases, with some studies indicating an annual increase of 3-12%. Therapeutic vaccines offer a targeted approach, enhancing the immune response and improving patient outcomes, thus fueling market growth and investment in research and development. The growing incidence of chronic diseases is contributing to an increased demand for therapeutic vaccines. As conditions like cancer and autoimmune disorders rise, there is an increasing demand for innovative treatment options.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Application Set to Witness Substantial Growth
Based on the application, the market is divided into autoimmune disease vaccines, cancer vaccines, infectious disease vaccines, neurological disease vaccines, and others. Among these, infectious disease vaccine is expected to lead the market. These vaccines have been a cornerstone of public health for decades, preventing diseases such as measles, mumps, influenza, etc. The COVID-19 pandemic has further emphasized the importance of vaccines in controlling infectious diseases. The need for rapid vaccine development in response to emerging infection threats will likely continue to shape this segment, driving investment and innovation in vaccine research and development. The market for infectious disease vaccines is expected to expand significantly as new technologies, such as mRNA vaccines, gain traction.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America holds the largest share of the market due to the rising occurrence of infectious diseases and strong financial support from government and non-governmental organizations. The growing demand for personalized medicine, along with collaborations in research, further propels market growth in the region.
The key features of the market report include patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Founded in 2008, BioNTech SE is based in Mainz, Germany, the firm focuses on mRNA therapeutics, including vaccines for infectious diseases and immunotherapies for cancer. Their portfolio features the well-known COVID-19 vaccine, BNT162b2, along with the continued development of vaccines targeting malaria and other infectious illnesses.
Established in 2018, Brii Biosciences is based in China. The organization concentrates on creating pioneering therapies for infectious illnesses, such as its therapeutic vaccine option for HIV. Brii's portfolio features therapies for hepatitis B, focusing significantly on immunology.
GlobeImmune Inc. was founded in 1995 and is located in Louisville, USA. The firm creates therapeutic vaccines targeting cancer and infectious illnesses. Prominent offerings consist of its T-cell vaccine platform aimed at cancer and its research vaccines for HPV-associated conditions and chronic hepatitis B.
Immatics N.V., established in 2000, is based in Germany. The company specializes in developing adoptive T-cell therapies and cancer vaccines. Its product portfolio includes ACTengine® and its IMA therapeutic vaccines, the major indications aimed at various cancers, including solid tumors like melanoma and renal cell carcinoma.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Immune Response Biopharma, Immunitor, Inc., and Inovio Pharmaceuticals, among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share